Zenas BioPharma, Inc. (ZBIO)

Zenas BioPharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Jun 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Market Capitalization	432	342	-	-
Enterprise Value	121	-44	-	-
Last Close Price	10.33	8.19	-	-
Debt / Equity Ratio	0.00	0.00	0.87	0.03
Asset Turnover	0.08	0.02	0.70	-
Quick Ratio	6.39	6.12	2.44	2.59
Current Ratio	6.47	6.21	2.57	2.64
Return on Equity (ROE)	-115.47%	-93.22%	-102.89%	-
Return on Assets (ROA)	-56.70%	-46.76%	-23.77%	-
Return on Capital (ROIC)	-71.22%	-57.07%	-35.79%	-
Buyback Yield / Dilution	-1408.82%	-762.01%	-2.61%	-

Updated May 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q